Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
14 07 2020
Historique:
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 23 7 2020
Statut: ppublish

Résumé

Observational studies have suggested that the use of radial artery grafts for coronary artery bypass grafting may improve clinical outcomes compared with the use of saphenous vein grafts, but this has not been confirmed in randomized trials. To compare clinical outcomes between patients receiving radial artery vs saphenous vein grafts for coronary artery bypass grafting after long-term follow-up. Patient-level pooled analysis comparing radial artery vs saphenous vein graft in adult patients undergoing isolated coronary artery bypass grafting from 5 countries (Australia, Italy, Serbia, South Korea, and the United Kingdom), with enrollment from 1997 to 2009 and follow-up completed in 2019. Patients were randomized to undergo either radial artery (n = 534) or saphenous vein (n = 502) grafts for coronary artery bypass grafting. The primary outcome was a composite of death, myocardial infarction, or repeat revascularization and the secondary outcome was a composite of death or myocardial infarction. A total of 1036 patients were randomized (mean age, 66.6 years in the radial artery group vs 67.1 years in the saphenous vein group; 376 [70.4%] men in the radial artery group vs 351 [69.9%] in the saphenous vein group); 942 (90.9%) of the originally randomized patients completed 10 years of follow-up (510 in the radial artery group). At a median (interquartile range) follow-up of 10 (10-11) years, the use of the radial artery, compared with the saphenous vein, in coronary artery bypass grafting was associated with a statistically significant reduction in the incidence of the composite outcome of death, myocardial infarction, or repeat revascularization (220 vs 237 total events; 41 vs 47 events per 1000 patient-years; hazard ratio, 0.73 [95% CI, 0.61-0.88]; P < .001) and of the composite of death or myocardial infarction (188 vs 193 total events; 35 vs 38 events per 1000 patient-years; hazard ratio, 0.77 [95% CI, 0.63-0.94]; P = .01). In this individual participant data meta-analysis with a median follow-up of 10 years, among patients undergoing coronary artery bypass grafting, the use of the radial artery compared with the saphenous vein was associated with a lower risk of a composite of cardiovascular outcomes.

Identifiants

pubmed: 32662861
pii: 2768133
doi: 10.1001/jama.2020.8228
pmc: PMC7361649
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-187

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL152021
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Ann Thorac Surg. 2018 Apr;105(4):1109-1119
pubmed: 29453002
Circulation. 2008 Jun 3;117(22):2859-64
pubmed: 18506009
J Cardiothorac Surg. 2015 Oct 15;10:127
pubmed: 26466996
J Thorac Cardiovasc Surg. 2009 May;137(5):1093-100
pubmed: 19379973
Korean Circ J. 2012 Feb;42(2):107-12
pubmed: 22396698
Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1025-1030
pubmed: 31535147
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
N Am J Med Sci. 2010 Apr;2(4):170-3
pubmed: 22624135
J Am Heart Assoc. 2019 Nov 5;8(21):e013711
pubmed: 31663420
J Thorac Cardiovasc Surg. 2003 Jun;125(6):1363-71
pubmed: 12830056
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1031-1040
pubmed: 29059371
N Engl J Med. 2018 May 31;378(22):2069-2077
pubmed: 29708851
Eur J Cardiothorac Surg. 2015 Jan;47(1):59-65; discussion 65
pubmed: 24686003
N Engl J Med. 2019 Jan 31;380(5):437-446
pubmed: 30699314
J Am Heart Assoc. 2018 Jan 6;7(1):
pubmed: 29306899
J Thorac Cardiovasc Surg. 2019 May;157(5):1819-1825.e10
pubmed: 30551962

Auteurs

Mario Gaudino (M)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Umberto Benedetto (U)

Department of Cardiac Surgery, Bristol Heart Institute, Bristol, United Kingdom.

Stephen Fremes (S)

Department of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Karla Ballman (K)

Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.

Giuseppe Biondi-Zoccai (G)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.
Mediterranea Cardiocentro, Naples, Italy.

Art Sedrakyan (A)

Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.

Giuseppe Nasso (G)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Jai Raman (J)

Austin Hospital, Melbourne, Victoria, Australia.
Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Brian Buxton (B)

Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Philip A Hayward (PA)

Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Neil Moat (N)

NHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Peter Collins (P)

NHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Carolyn Webb (C)

NHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Miodrag Peric (M)

Dedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.

Ivana Petrovic (I)

Dedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.

Kyung J Yoo (KJ)

Yonsei University College of Medicine, Seoul, South Korea.

Irbaz Hameed (I)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Antonino Di Franco (A)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Marco Moscarelli (M)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Giuseppe Speziale (G)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

John D Puskas (JD)

Department of Cardiovascular Surgery, Mount Sinai St. Luke's, New York, New York.

Leonard N Girardi (LN)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

David L Hare (DL)

Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.

David P Taggart (DP)

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH